128 related articles for article (PubMed ID: 32268159)
1. Cyto-genotoxic evaluation of novel anti-tubercular copper (II) complexes containing isoniazid-based ligands.
Fregonezi NF; Aparecida de Souza F; Aleixo NA; Stefany da Silva Gomes P; Silvestre RB; De Grandis RA; Bento da Silva P; Pavan FR; Chorilli M; Resende FA
Regul Toxicol Pharmacol; 2020 Jun; 113():104653. PubMed ID: 32268159
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of copper(II) complexes with isoniazid-derived hydrazones as anticancer and antitubercular agents.
Firmino GS; de Souza MV; Pessoa C; Lourenco MC; Resende JA; Lessa JA
Biometals; 2016 Dec; 29(6):953-963. PubMed ID: 27591998
[TBL] [Abstract][Full Text] [Related]
3. In Vitro Activity of Copper(II) Complexes, Loaded or Unloaded into a Nanostructured Lipid System, against Mycobacterium tuberculosis.
Silva PB; Souza PC; Calixto GM; Lopes Ede O; Frem RC; Netto AV; Mauro AE; Pavan FR; Chorilli M
Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27196901
[TBL] [Abstract][Full Text] [Related]
4. Potential of Casiopeínas® Copper Complexes and Antituberculosis Drug Combination against Mycobacterium tuberculosis.
Barbosa AR; Caleffi-Ferracioli KR; Leite CQ; García-Ramos JC; Toledano-Magaña Y; Ruiz-Azuara L; Siqueira VL; Pavan FR; Cardoso RF
Chemotherapy; 2016; 61(5):249-55. PubMed ID: 26950478
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic studies of a three-component complex that repurposes the front line antibiotic isoniazid against Mycobacterium tuberculosis.
Manning TJ; Wilkerson K; Holder T; Bartley AC; Jackson C; Plummer S; Phillips D; Krajewski L; Wylie G
Tuberculosis (Edinb); 2017 Dec; 107():149-155. PubMed ID: 29050764
[TBL] [Abstract][Full Text] [Related]
6. In vitro evaluation of the cyto-genotoxic potential of Ruthenium(II) SCAR complexes: a promising class of antituberculosis agents.
De Grandis RA; Resende FA; da Silva MM; Pavan FR; Batista AA; Varanda EA
Mutat Res Genet Toxicol Environ Mutagen; 2016 Mar; 798-799():11-8. PubMed ID: 26994489
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and mechanistic investigation of iron(II) complexes of isoniazid and derivatives as a redox-mediated activation strategy for anti-tuberculosis therapy.
Laborde J; Deraeve C; de Mesquita Vieira FG; Sournia-Saquet A; Rechignat L; Villela AD; Abbadi BL; Macchi FS; Pissinate K; Bizarro CV; Machado P; Basso LA; Pratviel G; de França Lopes LG; Sousa EHS; Bernardes-Génisson V
J Inorg Biochem; 2018 Feb; 179():71-81. PubMed ID: 29175704
[TBL] [Abstract][Full Text] [Related]
8. Copper(I) and silver(I) complexes of anthraldehyde thiosemicarbazone: synthesis, structure elucidation,
Khan A; Paul K; Singh I; Jasinski JP; Smolenski VA; Hotchkiss EP; Kelley PT; Shalit ZA; Kaur M; Banerjee S; Roy P; Sharma R
Dalton Trans; 2020 Dec; 49(47):17350-17367. PubMed ID: 33210698
[TBL] [Abstract][Full Text] [Related]
9. Isoniazid-related copper(II) and nickel(II) complexes with antimycobacterial in vitro activity. Part 9.
Bottari B; Maccari R; Monforte F; Ottanà R; Rotondo E; Vigorita MG
Bioorg Med Chem Lett; 2000 Apr; 10(7):657-60. PubMed ID: 10762047
[TBL] [Abstract][Full Text] [Related]
10. Nanostructured lipid carriers for incorporation of copper(II) complexes to be used against
Sato MR; Oshiro Junior JA; Machado RT; de Souza PC; Campos DL; Pavan FR; da Silva PB; Chorilli M
Drug Des Devel Ther; 2017; 11():909-921. PubMed ID: 28356717
[TBL] [Abstract][Full Text] [Related]
11. Development of a three component complex to increase isoniazid efficacy against isoniazid resistant and nonresistant Mycobacterium tuberculosis.
Manning T; Plummer S; Baker T; Wylie G; Clingenpeel AC; Phillips D
Bioorg Med Chem Lett; 2015 Oct; 25(20):4621-7. PubMed ID: 26341133
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, characterization and antitubercular activities of novel pyrrolyl hydrazones and their Cu-complexes.
Joshi SD; Kumar D; Dixit SR; Tigadi N; More UA; Lherbet C; Aminabhavi TM; Yang KS
Eur J Med Chem; 2016 Oct; 121():21-39. PubMed ID: 27214509
[TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of antituberculars: preparation and evaluation against Mycobacterium tuberculosis of an isoniazid Schiff base.
Hearn MJ; Cynamon MH
J Antimicrob Chemother; 2004 Feb; 53(2):185-91. PubMed ID: 14688045
[TBL] [Abstract][Full Text] [Related]
14. Metal complexes of isonicotinylhydrazide and their antitubercular activity.
Ali M; Ahmed M; Hafiz S; Kamal M; Mumtaz M; Hanif M; Khan KM
Pak J Pharm Sci; 2017 Nov; 30(6(Supplementary)):2399-2403. PubMed ID: 29188776
[TBL] [Abstract][Full Text] [Related]
15. Study of the cytotoxic and genotoxic potential of the carbonyl ruthenium(II) compound, ct-[RuCl(CO)(dppb)(bipy)]PF
Carnizello AP; Alves JM; Pereira DE; Campos JCL; Barbosa MIF; Batista AA; Tavares DC
J Appl Toxicol; 2019 Apr; 39(4):630-638. PubMed ID: 30460706
[TBL] [Abstract][Full Text] [Related]
16. Copper(II) Complexes with Saccharinate and Glutamine as Antitumor Agents: Cytoand Genotoxicity in Human Osteosarcoma Cells.
Cadavid-Vargas JF; Leon IE; Etcheverry SB; Santi E; Torre MH; Di Virgilio AL
Anticancer Agents Med Chem; 2017; 17(3):424-433. PubMed ID: 27173967
[TBL] [Abstract][Full Text] [Related]
17. Antitubercular activity of Ru (II) isoniazid complexes.
Aguiar Id; Tavares A; Roveda AC; da Silva AC; Marino LB; Lopes ÉO; Pavan FR; Lopes LG; Franco DW
Eur J Pharm Sci; 2015 Apr; 70():45-54. PubMed ID: 25638418
[TBL] [Abstract][Full Text] [Related]
18. Copper complex with sulfamethazine and 2,2'-bipyridine supported on mesoporous silica microspheres improves its antitumor action toward human osteosarcoma cells: cyto- and genotoxic effects.
Cadavid-Vargas JF; Arnal PM; Mojica Sepúlveda RD; Rizzo A; Soria DB; Di Virgilio AL
Biometals; 2019 Feb; 32(1):21-32. PubMed ID: 30334122
[TBL] [Abstract][Full Text] [Related]
19. 8-Hydroxyquinolines Are Boosting Agents of Copper-Related Toxicity in Mycobacterium tuberculosis.
Shah S; Dalecki AG; Malalasekera AP; Crawford CL; Michalek SM; Kutsch O; Sun J; Bossmann SH; Wolschendorf F
Antimicrob Agents Chemother; 2016 Oct; 60(10):5765-76. PubMed ID: 27431227
[TBL] [Abstract][Full Text] [Related]
20. Lower cytotoxicity, high stability, and long-term antibacterial activity of a poly(methacrylic acid)/isoniazid/rifampin nanogel against multidrug-resistant intestinal Mycobacterium tuberculosis.
Chen T; Li Q; Guo L; Yu L; Li Z; Guo H; Li H; Zhao M; Chen L; Chen X; Zhong Q; Zhou L; Wu T
Mater Sci Eng C Mater Biol Appl; 2016 Jan; 58():659-65. PubMed ID: 26478357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
